Your session is about to expire
← Back to Search
Other
Plasma Transfusion for Aging (RESET-YOUTH Trial)
Phase 1 & 2
Waitlist Available
Led By Chandra s duggirala
Research Sponsored by Chandra Duggirala
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline,1,2,3,4,5,6, and 9 months.
Awards & highlights
Summary
This trial studies the effects of regular treatments using plasma from young healthy male donors on patients older than 40 years. The goal is to see if the young plasma can rejuvenate the body and improve functions like cognition, muscle strength, and organ health.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline,1,2,3,4,5,6, and 9 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline,1,2,3,4,5,6, and 9 months.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Biological age as assessed by DNA methylation levels, to calculate the Epigenetic age.
Secondary study objectives
DHEAS
Estrogen
High Sensitivity C-Reactive Protein
+8 moreOther study objectives
Exploratory biomarkers
Trial Design
1Treatment groups
Experimental Treatment
Group I: Plasma TransfusionExperimental Treatment1 Intervention
Plasma Transfusions with 2 units of plasma per dose, for a total of 6 doses
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Chandra DuggiralaLead Sponsor
Chandra s duggiralaPrincipal InvestigatorFountain Labs, Inc.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger